Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: SusieQ1065 who wrote (77425)	10/14/2002 12:51:25 AM
From: Frederick Langford	Read Replies (1) \| Respond to of 208838

Don Sew's Chat Notes 10/13 8:00 PM Daily Signals: DOW, NAZ, SPX, OEX, SOX : UPPER MIDRANGE NDX : Borderline OVERBOUGHT RUT : MIDRANGE USD : LOWER MIDRANGE HUI, VIX : MIDRANGE/LOWER MIDRANGE VIX has an Island Reversal. DOW, NAZ, SPX, OEX, SOX: have double large white candles next to each other, which could limit the upside, or set up a short term pull back. Donald sold his entire long mutual fund position, and opened a small short mutual fund position on Friday. He also sold 3 of his four long option positions, and hedged the 4th with his short fund position. Donald thinks there is a good chance that an intermediate term bottom has been set, and that a pull back will likely set a higher low. He is planning on establishing long positions on any pull back that fills the gap on the NDX around 850. He is not expecting a pull back to be large enough to produce a CLASS 1 BUY signal, but does not rule it out. He noticed that the Net New High-New Lows improved greatly which is bullish, unless they reverse down. The NDX has rallied 13% already. There are weekly Imperfect Bullish Engulfing patterns on the DOW, SPX, OEX, and NAZ, and a near perfect weekly Bullish Engulfing on the NDX. The RUT has a perfect Hammer/Dragonfly Doji. The Capitulation Indicator has a daily reading of 4.9 as of Friday. It has turned down and gone vertical. On Friday it broke below the lower trend line of its rising flag, which is bullish for the market and bearish for the indicator.

To: SusieQ1065 who wrote (77425)	10/14/2002 1:05:58 AM
From: X Y Zebra	Read Replies (1) \| Respond to of 208838

evening Ms Q... and look at that gap too... ah chess game with the maniacs.. that's what next week will be like. Op Ex and all that... never a dull moment. just noticed another gap (in this instance to the upside on the VIX in early Sept...) got filled after topping against the upper band of the channel... So a repeat after a couple of days or so.... ? possibly... but one never knows. I also noticed the following in AMZN.... (related to Op Ex) Message 18105216 and now... time for a movie.... ;~)

To: SusieQ1065 who wrote (77425)	10/14/2002 5:58:49 AM
From: 2MAR$	Respond to of 208838

Looks like ADRX has gotten caught up in the perfect storm for today with this latest Prilosec ruling , will be taking a little dive...I had noticed it all of a sudden start to fall off from the $23's a week ago ...who knew ? chart stockcharts.com[h,a]daclyyay[pb50!b200][vc60][iUc20!La12,26,9]&pref=G ( for all the big dippers out there ) quote.bloomberg.com Prilosec was one of the world's best-selling drugs last year, bringing $5.7 billion in revenue for AstraZeneca, with $3.7 billion coming from the U.S. Monheim, Germany-based Schwarz, which had sales of 768 million euros ($758 million) last year, should capture some of that market, analysts said. ``This is about the best-case scenario for Schwarz,'' ING Financial Markets analyst Max Herrmann said. ``Almost all Prilosec sales will go generic.'' In her ruling, U.S. District Judge Barbara S. Jones found that three other drugmakers, Merck KGaA, Andrx Corp. and Dr. Reddy's Laboratories Ltd., infringed AstraZeneca's patents. That will block those companies from selling the drug until 2007, unless they win appeals or find another way around the patents. Andrx Investments Shares of Davie, Florida-based Andrx may lose half their value tomorrow, said John Borzilleri, an analyst at State Street Research, which held 1.86 million Andrx shares as of June. ``Obviously, we're extremely disappointed by the court's decision,'' Andrx Chairman and President Elliot Hahn said in an interview. ``We believe there is value in Andrx as well as in the Prilosec franchise.'' Andrx is considering ``all options that would benefit our shareholders and consumers,'' Hahn said.

To: SusieQ1065 who wrote (77425)	10/15/2002 8:15:30 AM
From: 2MAR$	Read Replies (1) \| Respond to of 208838

Microsoft-MSFT will meet or beat expectations@GSCO...$51+ here on ISLD , their making a run-up on QLGC too from the start, BRCD is up 10% , QCOM in $33's I told ya they would magnet MSFT back up , this market is rigged ! LOL keep an eye on CCMP